Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy

Author： Scarlett Uciane K   Conejo-Garcia Jose R  

Publisher： Informa Healthcare

ISSN： 1747-4108

Source： Expert Review of Obstretrics and Gynecology, Vol.7, Iss.5, 2012-09, pp. : 413-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topotecan in the treatment of ovarian cancer

By Obel Jennifer   Fleming Gini  

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 2, 2006-11 ,pp. : 149-158

Informa Healthcare

Access to resources Recommend Favorite

Epithelial ovarian cancer and infertility treatment

By MacLean A. B.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 1, 2002-01 ,pp. : 7-8

Informa Healthcare

Access to resources Recommend Favorite

Cancer vaccines from melanoma to ovarian cancer: good immune responses obtained

By Dalgleish Angus  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 6, 2007-11 ,pp. : 725-727

Informa Healthcare

Access to resources Recommend Favorite

Novel drug-delivery strategies for the treatment of ovarian cancer

By Ho Emmanuel A   Allen Christine   Piquette-Miller Micheline  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 5, 2007-09 ,pp. : 587-593

Informa Healthcare

Access to resources Recommend Favorite

Systemic treatment for recurrent epithelial ovarian cancer

By Chia Whay Kuang   George Angela   Banerjee Susana  

Expert Review of Obstretrics and Gynecology, Vol. 8, Iss. 2, 2013-03 ,pp. : 161-168

Informa Healthcare

Access to resources Recommend Favorite